Ironwood Pharmaceuticals, Inc. - (IRWD): Price and Financial Metrics

Ironwood Pharmaceuticals, Inc. - (IRWD): $10.30

0.40 (+4.04%)

POWR Rating

Component Grades








Add IRWD to Watchlist
Sign Up

IRWD Price/Volume Stats

Current price $10.30 52-week high $12.66
Prev. close $9.90 52-week low $8.07
Day low $9.83 Volume 2,290,200
Day high $10.35 Avg. volume 2,289,414
50-day MA $9.46 Dividend yield N/A
200-day MA $10.19 Market Cap 1.61B

IRWD Stock Price Chart Interactive Chart >


  • IRWD scores best on the Quality dimension, with a Quality rank ahead of 92.13% of US stocks.
  • The strongest trend for IRWD is in Value, which has been heading down over the past 177 days.
  • IRWD ranks lowest in Sentiment; there it ranks in the 12th percentile.

IRWD Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for IRWD is -1.34 -- better than merely 5.1% of US stocks.
  • Of note is the ratio of IRONWOOD PHARMACEUTICALS INC's sales and general administrative expense to its total operating expenses; just 3.59% of US stocks have a lower such ratio.
  • Over the past twelve months, IRWD has reported earnings growth of -470.19%, putting it ahead of merely 3.16% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to IRONWOOD PHARMACEUTICALS INC, a group of peers worth examining would be KOS, CHK, JRVR, EQT, and SM.
  • Visit IRWD's SEC page to see the company's official filings. To visit the company's web site, go to

IRWD Valuation Summary

  • In comparison to the median Healthcare stock, IRWD's price/earnings ratio is 106.58% lower, now standing at -1.6.
  • Over the past 167 months, IRWD's EV/EBIT ratio has gone up 11.8.

Below are key valuation metrics over time for IRWD.

Stock Date P/S P/B P/E EV/EBIT
IRWD 2023-11-03 3.5 -4.3 -1.6 -2.5
IRWD 2023-11-02 3.3 -4.1 -1.5 -2.4
IRWD 2023-11-01 3.3 -4.1 -1.5 -2.4
IRWD 2023-10-31 3.3 -4.0 -1.5 -2.4
IRWD 2023-10-30 3.3 -4.0 -1.5 -2.4
IRWD 2023-10-27 3.2 -4.0 -1.5 -2.3

IRWD Growth Metrics

    Its 4 year cash and equivalents growth rate is now at 72.77%.
  • The 5 year price growth rate now stands at -33.93%.
  • Its 3 year cash and equivalents growth rate is now at 394.3%.
Over the past 34 months, IRWD's revenue has gone down $29,030,000.

The table below shows IRWD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 410.596 273.763 175.065
2022-09-30 420.527 259.149 167.572
2022-06-30 415.637 265.122 173.1
2022-03-31 422.437 252.325 527.323
2021-12-31 413.753 261.895 528.448
2021-09-30 413.303 248.84 530.278

IRWD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IRWD has a Quality Grade of B, ranking ahead of 94.53% of graded US stocks.
  • IRWD's asset turnover comes in at 0.622 -- ranking 50th of 682 Pharmaceutical Products stocks.
  • LGND, COLL, and OMER are the stocks whose asset turnover ratios are most correlated with IRWD.

The table below shows IRWD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.622 0.998 0.305
2021-03-31 0.761 0.998 0.286
2020-12-31 0.820 0.992 0.226
2020-09-30 0.916 0.967 0.230
2020-06-30 1.077 0.976 0.213
2020-03-31 1.207 0.951 0.198

IRWD Price Target

For more insight on analysts targets of IRWD, see our IRWD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $13.83 Average Broker Recommendation 1.71 (Moderate Buy)

Ironwood Pharmaceuticals, Inc. - (IRWD) Company Bio

Ironwood Pharmaceuticals engages in the research, development, and commercialization of human therapeutic products, with a key focus being the treatment of adult men and women suffering from irritable bowel syndrome. The company was founded in 1998 and is based in Cambridge, Massachusetts.

IRWD Latest News Stream

Event/Time News Detail
Loading, please wait...

IRWD Latest Social Stream

Loading social stream, please wait...

View Full IRWD Social Stream

Latest IRWD News From Around the Web

Below are the latest news stories about IRONWOOD PHARMACEUTICALS INC that investors may wish to consider to help them evaluate IRWD as an investment opportunity.

Ironwood Pharmaceuticals to Participate in the Piper Sandler 35th Annual Healthcare Conference

BOSTON, November 21, 2023--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) will participate in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023 at 9:00 a.m. ET at the Lotte New York Palace.

Yahoo | November 21, 2023

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2023 Earnings Call Transcript

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2023 Earnings Call Transcript November 9, 2023 Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.09 EPS, expectations were $0.17. Operator: Thank you for standing by. My name is Aaron, and I will be your conference operator for today. At this time, I would like to welcome everyone […]

Yahoo | November 10, 2023

Ironwood's (IRWD) Q3 Earnings Miss Mark, Linzess Volume Rises

Ironwood's (IRWD) third-quarter 2023 earnings miss estimates, while revenues beat the same. Linzess collaboration revenues drive the top line.

Yahoo | November 10, 2023

Q3 2023 Ironwood Pharmaceuticals Inc Earnings Call

Q3 2023 Ironwood Pharmaceuticals Inc Earnings Call

Yahoo | November 10, 2023

Ironwood Pharmaceuticals Inc (IRWD) Reports Growth in LINZESS Sales and Maintains Full Year Guidance

Third Quarter 2023 Financial Results and Business Highlights

Yahoo | November 9, 2023

Read More 'IRWD' Stories Here

IRWD Price Returns

1-mo 14.57%
3-mo 11.23%
6-mo -6.62%
1-year -15.99%
3-year -11.40%
5-year -25.36%
YTD -16.87%
2022 6.26%
2021 2.37%
2020 -14.43%
2019 28.47%
2018 -30.89%

Continue Researching IRWD

Here are a few links from around the web to help you further your research on Ironwood Pharmaceuticals Inc's stock as an investment opportunity:

Ironwood Pharmaceuticals Inc (IRWD) Stock Price | Nasdaq
Ironwood Pharmaceuticals Inc (IRWD) Stock Quote, History and News - Yahoo Finance
Ironwood Pharmaceuticals Inc (IRWD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!